Verrica Pharmaceuticals Inc. - Common Stock (VRCA)
0.6737
+0.0037 (0.55%)
Verrica Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing innovative treatments for dermatological conditions, particularly for skin diseases like warts and other cutaneous manifestations
The company is dedicated to advancing its proprietary product candidates that utilize a unique approach to deliver targeted therapies, aiming to improve patient outcomes and enhance the quality of life for individuals suffering from these conditions. By leveraging its expertise and cutting-edge technology, Verrica is committed to addressing unmet medical needs within the dermatology space.
Frequently Asked Questions
Is Verrica Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Verrica Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Verrica Pharmaceuticals Inc. - Common Stock trade on?
Verrica Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Verrica Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Verrica Pharmaceuticals Inc. - Common Stock is VRCA on the Nasdaq Stock Market
What is the current price of Verrica Pharmaceuticals Inc. - Common Stock?
The current price of Verrica Pharmaceuticals Inc. - Common Stock is 0.6737
When was Verrica Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Verrica Pharmaceuticals Inc. - Common Stock was at 4:00 pm EST on January 6th, 2025
What is the market capitalization of Verrica Pharmaceuticals Inc. - Common Stock?
The market capitalization of Verrica Pharmaceuticals Inc. - Common Stock is 28.27M
How many shares of Verrica Pharmaceuticals Inc. - Common Stock are outstanding?
Verrica Pharmaceuticals Inc. - Common Stock has 41.96M shares outstanding.